Hainan Poly Pharm Co Ltd (300630) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.015x

Based on the latest financial reports, Hainan Poly Pharm Co Ltd (300630) has a cash flow conversion efficiency ratio of 0.015x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.82 Million ≈ $6.56 Million USD) by net assets (CN¥3.01 Billion ≈ $440.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hainan Poly Pharm Co Ltd (300630) balance sheet quality index to measure how much of total assets are equity-financed.

Hainan Poly Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2023)

This chart illustrates how Hainan Poly Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hainan Poly Pharm Co Ltd (300630) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Hainan Poly Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Poly Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tridomain Performance Materials PT JK:TDPM	0.076x
Mukka Proteins Limited NSE:MUKKA	-0.022x
CMG Pharmaceutical Co. Ltd KQ:058820	-0.020x
Onano Industrial Corp TW:6405	-0.001x
Lokesh Machines Limited NSE:LOKESHMACH	-0.077x
AEC SECURITIES BK:BYD-R	N/A
Rama Steel Tubes Limited NSE:RAMASTEEL	-0.060x
Intellicheck Mobilisa Inc NASDAQ:IDN	0.116x

Annual Cash Flow Conversion Efficiency for Hainan Poly Pharm Co Ltd (2016–2023)

The table below shows the annual cash flow conversion efficiency of Hainan Poly Pharm Co Ltd from 2016 to 2023. For the full company profile with market capitalisation and key ratios, see 300630 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	CN¥2.91 Billion ≈ $425.27 Million	CN¥112.72 Million ≈ $16.49 Million	0.039x	-79.66%
2022-12-31	CN¥2.80 Billion ≈ $410.10 Million	CN¥534.29 Million ≈ $78.18 Million	0.191x	+208.59%
2021-12-31	CN¥2.54 Billion ≈ $371.94 Million	CN¥157.03 Million ≈ $22.98 Million	0.062x	-62.06%
2020-12-31	CN¥2.04 Billion ≈ $298.39 Million	CN¥332.08 Million ≈ $48.59 Million	0.163x	-13.35%
2019-12-31	CN¥1.15 Billion ≈ $167.69 Million	CN¥215.37 Million ≈ $31.52 Million	0.188x	+75.14%
2018-12-31	CN¥883.26 Million ≈ $129.25 Million	CN¥94.79 Million ≈ $13.87 Million	0.107x	-17.46%
2017-12-31	CN¥721.37 Million ≈ $105.56 Million	CN¥93.79 Million ≈ $13.72 Million	0.130x	-28.09%
2016-12-31	CN¥307.12 Million ≈ $44.94 Million	CN¥55.53 Million ≈ $8.13 Million	0.181x	--

About Hainan Poly Pharm Co Ltd

SHE:300630 China Drug Manufacturers - Specialty & Generic

Market Cap

$73.10 Million

CN¥499.57 Million CNY

Market Cap Rank

#20340 Global

#4686 in China

Share Price

CN¥0.89

Change (1 day)

+0.00%

52-Week Range

CN¥0.89 - CN¥0.89

All Time High

CN¥70.54